Skip to content
Menu

RLX Technology Inc. RLX

Full chart Compare
Set alert

Price alert · RLX

All alert types
1.40 USD -0.06 (-4.11%)

Regular-session close

1.38 -0.02 -1.43%

After hours · Nov 20, 5:20 PM ET

1.31 Day range 1.45
1.31 52-week range 2.55
YTD
-39.91%
1 year
-43.55%

Fundamental scorecard

16 of 25 checks passed on RLX’s reported financials

ValueGrowthProfitabilityHealthDividend

16of 25 checks passed

  • Value 5 of 5
  • Growth 4 of 5
  • Profitability 2 of 5
  • Financial health 5 of 5
  • Dividend No data

Statements to Jun 30, 2026.

Value 5 of 5

  • Passed:P/E below its own 5-year median P/E 11.7 against a 5-year median of 21.7.
  • Passed:P/E under 20 P/E 11.7: an earnings yield of 8.5%.
  • Passed:Price to sales below its own 5-year median Price to sales 2.4 against a 5-year median of 5.0.
  • Passed:Price to book below its own 5-year median Price to book 0.7 against a 5-year median of 1.4.
  • Passed:Free cash flow yield above 4% Free cash flow of 536M is 4.6% of the market value.

Growth 4 of 5

  • Passed:Revenue grew over the last year Revenue of 4.87B is +49.4% on the 12 months before.
  • Failed:Revenue grew more than 5% a year over five years +0.7% a year from FY 2020 to FY 2025.
  • Passed:Earnings per share grew over the last year EPS 0.71 against 0.56 in the 12 months before.
  • Passed:Earnings per share grew more than 5% a year over five years EPS -0.09 in FY 2020, 0.70 in FY 2025.
  • Passed:Analysts expect higher earnings per share over the next year The average forward estimate is +48.6% on the last 12 months.

Profitability 2 of 5

  • Passed:Profitable over the last year Net income of 985M over the last 12 months.
  • Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Return on equity of 6.2%.
  • Failed:Net margin above its 5-year average Net margin of 20.2% against a 5-year average of 25.6%.
  • Failed:Free cash flow is at least 80% of net income Free cash flow of 536M is 54.4% of net income.

Financial health 5 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 10.8B against short-term liabilities of 1.02B.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 10.8B against long-term liabilities of 208M.
  • Passed:Net debt under 40% of equity More cash than debt: 8.97B of cash against 244M of debt.
  • Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 536M is 219.5% of debt.
  • Passed:Operating profit covers interest at least 3 times No interest expense reported.

Dividend No data

  • No data:Pays a dividend Not enough data to decide.
  • No data:Yield above 1.5% Not enough data to decide.
  • No data:Pays out under 75% of profit Not enough data to decide.
  • No data:Covered by free cash flow Not enough data to decide.
  • No data:Not cut in the last five fiscal years Not enough data to decide.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What RLX owns and owes, as of Jun 30, 2026

Short term and long term

Balance sheet · 16.9B of assets

Debt, equity and cash by year

Now: 8.73B more cash than debt

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings, in its reporting currency.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

7.04 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A+4 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 5
  • P/E 3
  • P/B 4

Valuation

P/E 23.3×
P/S 5.7×
P/B 1.3×
P/FCF 20.2×
EV/EBITDA 13.0×
EV/Sales 4.1×
FCF Yield 4.9%

Profitability

Gross Margin 32.7%
Operating Margin 9.1%
Net Margin 25.5%
ROE 5.7%
ROIC 1.8%
ROA 5.0%

Growth (YoY)

Revenue 43.9%
Operating Income 398.3%
EPS (diluted) 62.8%
Free Cash Flow 17.1%

Financial Health

Current Ratio 5.7×
Quick Ratio 5.6×
Debt / Equity 0.0×
Net Debt / EBITDA -4.8×
Interest Coverage 0.0×

Dividends

Dividend Yield 0.5%
Payout Ratio 10.2%

Annual · latest fiscal year ends 2025-12-31